Hepion Pharmaceuticals, Inc.
USE OF CYCLOSPORINE ANALOGUES FOR TREATING CANCER

Last updated:

Abstract:

Disclosed herein include methods, compositions, and kits suitable for use in preventing and treating proliferative diseases such as cancer. The methods comprise administering to a subject in need thereof a composition comprising a cyclosporine analogue (e.g., CRV431), or a pharmaceutically acceptable salt, solvate, stereoisomer thereof. The compositions and kits comprise a cyclosporine analogue (e.g., CRV431), or a pharmaceutically acceptable salt, solvate, stereoisomer thereof.

Status:
Application
Type:

Utility

Filling date:

24 Feb 2021

Issue date:

2 Sep 2021